|Articles|November 10, 2022
- Applied Clinical Trials-11-01-2022
- Volume 31
- Issue 11
Applied Clinical Trials November 2022 Issue (PDF)
Advertisement
Articles in this issue
over 3 years ago
Mobilizing and Maintaining Clinical Trials in Midst of Warover 3 years ago
The Implications of Inflation for Drug Developmentover 3 years ago
When Does Patient Centricity Equal Burden?over 3 years ago
The State of Data FAIRification in Clinical Researchalmost 4 years ago
“Culture of Quality” In Actionalmost 4 years ago
FDA Expands Oversight of Cell and Gene Therapiesalmost 4 years ago
Anticipating Careless Responders in Survey Design and Analysisabout 4 years ago
Towards a Global Implementation of eConsent in Clinical TrialsAdvertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief: Portfolio-Level Recruitment Strategy, Structural Change Through Systems Thinking, and Kidney Function Preservation in IgAN
2
Patient Recruitment in Clinical Trials: Why the Industry's Longstanding Approach Is No Longer Fit for Purpose
3
Precision Oncology Trials Need to Reflect the Complexity of Cancer Biology
4
ACT Brief: Local-First Communication Design, RBQM Financial Impact, and First Oral PCSK9 Inhibitor
5